18 articles
Blood sugar below 55 mg/dL can cause seizures or coma, while levels above 600 mg/dL signal a life-threatening emergency every diabetic should recognize.
Lifestyle changes cut chronic disease risk by 21% in prediabetes patients, outperforming metformin across a landmark 21-year study.
GLP-1 drugs are transforming PCOS treatment by targeting insulin resistance, the root cause of the condition now renamed PMOS by The Lancet in 2026.
A Canadian trial will test whether tirzepatide can help type 1 diabetes patients achieve fully automated insulin control without counting carbs.
The FDA approved the first OTC continuous glucose monitor for children ages 2 and up, letting families track blood sugar without a prescription.
Healthy college students wearing glucose monitors discovered surprising blood sugar spikes from stress and specific foods, leading to lasting diet changes.
A new oral GLP-1 pill for type 2 diabetes helped 72% of patients lose weight, offering hope for the 30% of adults who avoid shots due to needle fear.
Modern diabetes care now protects hearts, kidneys, and nerves with breakthrough medications that go far beyond blood sugar control alone.
People with type 1 diabetes can safely enjoy hiking and camping with proper preparation, backup supplies, and blood sugar management strategies.
Artificial sweeteners don't spike blood sugar immediately, but heavy daily use may increase diabetes risk by 20-40% over time.
Diabetes technology isn't one-size-fits-all: CGMs and insulin pumps must match your lifestyle, age, and comfort level to work effectively.
GLP-1 drugs now treat liver disease, kidney problems, and sleep apnea beyond diabetes, with semaglutide resolving liver damage in 63% of patients.
A new 12-week online program using plant-based nutrition costs $50 weekly versus $300-$400 for GLP-1 drugs, with research showing the diet may reverse type 2...
Doctors increasingly prescribe GLP-1s, metformin, and SGLT-2 inhibitors off-label to people with type 1 diabetes to reduce insulin needs and manage weight, but...
Diabetic peripheral neuropathy affects up to 50% of diabetes patients, yet new diagnostic advances and biomarkers offer hope for earlier detection and better...
Modern diabetes care has abandoned one-size-fits-all treatment. Doctors now use a layered, evidence-based approach that adjusts medications based on your...
Metformin, a cheap century-old drug, helps people with type 1 diabetes use 12% less insulin while maintaining stable blood sugar, according to a new clinical...
Stanford researchers discovered genetic variants in about 10% of people make GLP-1 diabetes medications less effective at lowering blood sugar, despite higher...
